5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
SELL | SELL | SELL | SELL | BUY |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 2.88▼ | 2.88▼ | 2.86▲ | 2.89▼ | 2.89▼ |
MA10 | 2.88▼ | 2.86▲ | 2.85▲ | 2.90▼ | 2.86▲ |
MA20 | 2.89▼ | 2.85▲ | 2.89▼ | 2.95▼ | 2.87▲ |
MA50 | 2.85▲ | 2.90▼ | 2.90▼ | 2.82▲ | 2.75▲ |
MA100 | 2.85▲ | 2.91▼ | 2.94▼ | 2.84▲ | 2.60▲ |
MA200 | 2.90▼ | 2.94▼ | 2.93▼ | 2.74▲ | 3.37▼ |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | -0.003▼ | 0.008▲ | 0.001▲ | -0.018▼ | 0.002▲ |
RSI | 45.254▼ | 49.639▼ | 46.591▼ | 47.900▼ | 51.035▲ |
STOCH | 33.333 | 87.037▲ | 53.492 | 29.444 | 67.510 |
WILL %R | -100.000▼ | -27.778 | -45.833 | -78.788▼ | -47.173 |
CCI | -308.333▼ | 57.351 | 25.564 | -105.479▼ | 4.748 |
Monday, June 16, 2025 04:00 AM
The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he ...
|
Thursday, June 12, 2025 06:04 AM
June 16, 2025 Rutherford, NJ, June 12, 2025 (GLOBE NEWSWIRE) -- Glucotrack, Inc. (Nasdaq: GCTK) (“Glucotrack” or the “Company”), a medical technology company focused on the design, development, and ...
|
Wednesday, June 11, 2025 04:14 AM
The FDA has authorized the Expanded Access Program (EAP) for the investigational imaging agent MNPR-101-Zr and therapeutic agent MNPR-101-Lu, allowing patients with advanced solid tumors access to ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
16/06/25 | 2.88 | 2.895 | 2.82 | 2.87 | 815,238 |
13/06/25 | 2.86 | 2.88 | 2.80 | 2.80 | 2,660,200 |
12/06/25 | 2.92 | 2.98 | 2.91 | 2.92 | 3,035,400 |
11/06/25 | 2.90 | 2.97 | 2.90 | 2.94 | 1,732,200 |
10/06/25 | 2.91 | 2.93 | 2.875 | 2.90 | 1,969,182 |
09/06/25 | 2.92 | 2.965 | 2.88 | 2.88 | 5,468,369 |
06/06/25 | 2.93 | 2.93 | 2.85 | 2.90 | 2,221,200 |
05/06/25 | 2.97 | 3.00 | 2.92 | 2.92 | 2,004,591 |
04/06/25 | 2.89 | 2.9701 | 2.89 | 2.96 | 1,617,698 |
03/06/25 | 2.94 | 2.97 | 2.83 | 2.88 | 1,851,265 |
|
|
||||
|
|
||||
|
|